BTN3A1

BTN3A1 분자 정보

영어 이름Butyrophilin subfamily 3 member A1시판 약물 수0
임상 약물 수1표적 별명BTF5,BTN3A1,CD_antigen,BTN3.1,BT3.1,DJ45P21.3 (Butyrophilin, Subfamily 3, Member A1),Butyrophilin, Subfamily 3, Member A1,CD277 Antigen
최고 연구 개발 단계Phase 2 Clinical
영어 이름Butyrophilin subfamily 3 member A1
표적 별명BTF5,BTN3A1,CD_antigen,BTN3.1,BT3.1,DJ45P21.3 (Butyrophilin, Subfamily 3, Member A1),Butyrophilin, Subfamily 3, Member A1,CD277 Antigen
시판 약물 수0
임상 약물 수1
최고 연구 개발 단계Phase 2 Clinical

BTN3A1 제품 목록

  • 속성

    Protein (3)

  • 제품 라이브러리

    온라인 (3)

  • Human (3)

  • 태그

    Fc Tag (1)His Tag & Avi Tag (1)His Tag (1)

  • 마커

    Unconjugated (2)Biotin-labeled (1)

BTN3A1분자 배경

Butyrophilin subfamily 3 member A1 (BTN3A1) is also known as CD277 and BTF5, which belongs to the immunoglobulin superfamily and contains one B30.2/SPRY domain and two Ig-like V-type (immunoglobulin-like) domains. BTN3A1 plays a role in T-cell activation and in the adaptive immune response. Also, BTN3A1 regulates the proliferation of activated T-cells and the release of cytokines and IFNG by activated T-cells. Furthermore, BTN3A1 mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate.

BTN3A1분자 별명

BTN3A1,CD277,BTF5

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
ICT-01(Imcheck Therapeutics)ICT-01Phase 2 ClinicalImCheck Therapeutics SASHematologic Neoplasms; Lymphoma; Neoplasms; Solid tumours
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호